Page last updated: 2024-09-05

anemodeanin a and Carcinoma, Non-Small Cell Lung

anemodeanin a has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Hu, Y; Jin, Z; Li, Z; Qian, J; Tang, X; Teng, Y; Wang, R; Xing, Y; Xue, W1
Cao, X; Jiang, Y; Lin, L; Luo, X; Wu, X1
Cai, R; Chen, M; Li, G; Li, L1

Other Studies

3 other study(ies) available for anemodeanin a and Carcinoma, Non-Small Cell Lung

ArticleYear
Raddeanin A promotes autophagy-induced apoptosis by inactivating PI3K/AKT/mTOR pathway in lung adenocarcinoma cells.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:9

    Topics: Adenocarcinoma of Lung; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Humans; Lung Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases

2023
Raddeanin A Improves the Therapeutic Effect of Osimertinib in NSCLC by Accelerating ROS/NLRP3-mediated Pyroptosis.
    Current pharmaceutical design, 2023, Volume: 29, Issue:32

    Topics: Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Humans; Lung Neoplasms; Mutation; NLR Family, Pyrin Domain-Containing 3 Protein; Protein Kinase Inhibitors; Pyroptosis; Reactive Oxygen Species

2023
Raddeanin A induced apoptosis of non-small cell lung cancer cells by promoting ROS-mediated STAT3 inactivation.
    Tissue & cell, 2021, Volume: 71

    Topics: A549 Cells; Apoptosis; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Neoplasm Proteins; Reactive Oxygen Species; Saponins; STAT3 Transcription Factor

2021